Andon Health Co., Ltd. (002432.SZ)
CNY 42.22
(-0.31%)
CNY 42.22
(-0.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.69 Billion CNY | -95.5% |
| 2022 | 18.4 Billion CNY | 1620.64% |
| 2021 | 1.11 Billion CNY | 31.61% |
| 2020 | 342.28 Million CNY | 1107.15% |
| 2019 | 100.69 Million CNY | -152.17% |
| 2018 | 58.6 Million CNY | 282.2% |
| 2017 | -88.71 Million CNY | -268.77% |
| 2016 | 65.01 Million CNY | 143.73% |
| 2015 | -126.57 Million CNY | -344.12% |
| 2014 | 34.81 Million CNY | 343.93% |
| 2013 | 4.58 Million CNY | -32.44% |
| 2012 | 14.24 Million CNY | -47.03% |
| 2011 | 30.05 Million CNY | -6.18% |
| 2010 | 32.06 Million CNY | -33.62% |
| 2009 | 48.62 Million CNY | 33.41% |
| 2008 | 36.77 Million CNY | -17.47% |
| 2007 | 44.74 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 476.74 Million CNY | -13.64% |
| 2024 Q3 | 991.94 Million CNY | 183.94% |
| 2024 Q2 | 349.35 Million CNY | -8.28% |
| 2023 Q4 | -34.7 Million CNY | -123.28% |
| 2023 Q2 | 420.46 Million CNY | -49.43% |
| 2023 Q3 | 149.07 Million CNY | -64.54% |
| 2023 Q1 | 831.49 Million CNY | 152.53% |
| 2023 FY | - CNY | -95.5% |
| 2022 Q2 | 880.44 Million CNY | -94.78% |
| 2022 Q4 | 329.26 Million CNY | -61.17% |
| 2022 FY | - CNY | 1620.64% |
| 2022 Q1 | 16.87 Billion CNY | 1592.32% |
| 2022 Q3 | 847.94 Million CNY | -3.69% |
| 2021 Q3 | -28.64 Million CNY | -164.4% |
| 2021 FY | - CNY | 31.61% |
| 2021 Q4 | 996.97 Million CNY | 3580.83% |
| 2021 Q1 | 4.14 Million CNY | -84.01% |
| 2021 Q2 | 44.47 Million CNY | 972.9% |
| 2020 Q1 | 389.79 Million CNY | 836.61% |
| 2020 FY | - CNY | 1107.15% |
| 2020 Q2 | 266.52 Million CNY | -31.62% |
| 2020 Q4 | 25.92 Million CNY | -73.08% |
| 2020 Q3 | 96.33 Million CNY | -63.86% |
| 2019 Q2 | -11.82 Million CNY | 74.0% |
| 2019 Q1 | -45.47 Million CNY | -123.58% |
| 2019 Q4 | -52.91 Million CNY | -62.25% |
| 2019 FY | - CNY | -152.17% |
| 2019 Q3 | -32.61 Million CNY | -175.88% |
| 2018 Q2 | -32.27 Million CNY | -17.07% |
| 2018 Q1 | -27.56 Million CNY | 1.75% |
| 2018 FY | - CNY | 282.2% |
| 2018 Q4 | 192.82 Million CNY | 936.78% |
| 2018 Q3 | -23.04 Million CNY | 28.61% |
| 2017 Q3 | -53.77 Million CNY | -472.88% |
| 2017 Q4 | -28.06 Million CNY | 47.82% |
| 2017 FY | - CNY | -268.77% |
| 2017 Q1 | -18.81 Million CNY | -116.78% |
| 2017 Q2 | -9.38 Million CNY | 50.11% |
| 2016 FY | - CNY | 143.73% |
| 2016 Q1 | -14.54 Million CNY | 81.26% |
| 2016 Q3 | -47.18 Million CNY | -43.54% |
| 2016 Q4 | 112.11 Million CNY | 337.6% |
| 2016 Q2 | -32.87 Million CNY | -125.95% |
| 2015 Q1 | -14.14 Million CNY | -122.34% |
| 2015 Q2 | -33.87 Million CNY | -139.58% |
| 2015 FY | - CNY | -344.12% |
| 2015 Q3 | -18.85 Million CNY | 44.36% |
| 2015 Q4 | -77.63 Million CNY | -311.84% |
| 2014 Q2 | -6.74 Million CNY | -1025.54% |
| 2014 Q1 | 729.05 Thousand CNY | 116.92% |
| 2014 Q4 | 63.31 Million CNY | 376.57% |
| 2014 FY | - CNY | 343.93% |
| 2014 Q3 | -22.89 Million CNY | -239.26% |
| 2013 Q1 | -3.25 Million CNY | -127.75% |
| 2013 FY | - CNY | -32.44% |
| 2013 Q2 | 10.14 Million CNY | 411.7% |
| 2013 Q3 | -2.31 Million CNY | -122.79% |
| 2013 Q4 | -4.3 Million CNY | -86.35% |
| 2012 Q1 | -3.27 Million CNY | -130.1% |
| 2012 FY | - CNY | -47.03% |
| 2012 Q4 | 11.72 Million CNY | 356.68% |
| 2012 Q3 | -4.56 Million CNY | -259.52% |
| 2012 Q2 | 2.86 Million CNY | 187.52% |
| 2011 Q3 | 7.74 Million CNY | -36.92% |
| 2011 Q2 | 12.27 Million CNY | 2316.14% |
| 2011 FY | - CNY | -6.18% |
| 2011 Q1 | 507.84 Thousand CNY | -93.07% |
| 2011 Q4 | 10.87 Million CNY | 40.48% |
| 2010 Q1 | 5.9 Million CNY | -74.57% |
| 2010 Q3 | 7.44 Million CNY | -12.74% |
| 2010 Q4 | 7.32 Million CNY | -1.61% |
| 2010 FY | - CNY | -33.62% |
| 2010 Q2 | 8.53 Million CNY | 44.53% |
| 2009 FY | - CNY | 33.41% |
| 2009 Q2 | 7.59 Million CNY | 26.62% |
| 2009 Q1 | 6 Million CNY | 0.0% |
| 2009 Q3 | 9.2 Million CNY | 21.1% |
| 2009 Q4 | 23.22 Million CNY | 152.34% |
| 2008 FY | - CNY | -17.47% |
| 2007 FY | - CNY | 0.0% |